Canadian National Pharma Group
Marcus Dahl is a prototypical intrapreneur. He has built his entire career by taking direct responsibility for turning an idea into a profitable finished product through assertive risk-taking and innovation. He has creative problem-solving and an eye for areas that can be streamlined, he drives consistent bottom-line improvements and shareholder returns. Marcus is excited to be working in the world of international pharmaceuticals as he sees the potential for growth financially but also as a way of improving world health overall. With a background in business growth, sales, new market development and staff supervision, Marcus moves the company forward with a fine balance of fiscal restraint, accountability and risk management.
Canadian National Pharma Group received its Health Canada processing licence on November 29, 2019.
You must sign in to reply to this listing.
